Related references
Note: Only part of the references are listed.HER-2 and topoisomerase II as predictors of response to chemotherapy
Kathleen I. Pritchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
Carey K. Anders et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
HER2 and response to paclitaxel in node-positive breast cancer
Daniel F. Hayes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: Nationwide survival data in Korea - A report from the Korean Breast Cancer Society
Sei Hyun Ahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
DA Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling
SJ Van Laere et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comorbidity and survival disparities among black and white patients with breast cancer
CM Tammemagi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Racial disparities in treatment and survival among women with early-stage breast cancer
D Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations
K Yu et al.
CLINICAL CANCER RESEARCH (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy
JJ Griggs et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
IC Henderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Very young women (<35 years) with operable breast cancer:: features of disease at presentation
M Colleoni et al.
ANNALS OF ONCOLOGY (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Stage 0 to stage III breast cancer in young women
C Gajdos et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2000)
Share Paper
